[Oral hypoglycemic agents--overview].
Sakamoto
N
N
Chubu-Rosai Hospital.
Uno
T
T
D020909:Acarbose; D000284:Administration, Oral; D001645:Biguanides / Q000494:pharmacology; D002839:Chromans / Q000494:pharmacology; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007294:Inositol / Q000031:analogs & derivatives / Q000494:pharmacology; D007333:Insulin Resistance; D013453:Sulfonylurea Compounds / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology; D045162:Thiazolidinediones; D014312:Trisaccharides / Q000494:pharmacology; D000077288:Troglitazone
D001645:Biguanides; D002839:Chromans; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D013844:Thiazoles; D045162:Thiazolidinediones; D014312:Trisaccharides; D007294:Inositol; D000077288:Troglitazone; C102817:voglibose; D020909:Acarbose